 |
인쇄하기
취소
|
Choong-wae, Fujirebio sign agreement over Lumipulse G1200
Choongwae-Pharm announced on August 11 that it has signed an exclusive distribution agreement with Fujirebio Diagnostics, Inc. of Japan to distribute the latter’s diagnostic agent “Lumipulse G1200.”
Lumipulse G1200 is a biomarker for cancer and other 40 diseases, which can be detected within a short period time.
“Fujirebio is investing in the development of tools and technologies essenti...
Lumipulse G1200 is a biomarker for cancer and other 40 diseases, which can be detected within a short period time.
“Fujirebio is investing in the development of tools and technologies essenti...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.